Facts & Data

Facts and data to help you understand brain and eye disease.

What can we help you find?

    Clear all
  • Fact Sheet

    Glaucoma: Facts & Figures

    More than 3 million Americans are living with glaucoma, and 2.7 million of whom-aged 40 and older-are affected by its most common form, open-angle glaucoma. Get the facts about glaucoma.

    Saturday, June 17, 2017
  • Fact Sheet

    Alzheimer’s Disease: Facts & Figures

    Every 66 seconds, someone in America develops Alzheimer's. It is estimated that nearly 500,000 new cases of Alzheimer's disease will be diagnosed this year. Get the facts about Alzheimer's disease—the most common form of dementia.

    Tuesday, March 7, 2017
  • Fact Sheet

    Treatments for Alzheimer's Disease

    Currently, there is no cure for Alzheimer’s disease. However, there are medications that can help control or delay its symptoms for some time, particularly in the early stages of the disease.

    Tuesday, October 25, 2016
  • Fact Sheet

    Clinical Trial Information for Macular Degeneration

    It can take many years for a potential treatment for macular degeneration to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    Tuesday, June 20, 2017
  • Fact Sheet

    Healthy Living with Alzheimer’s Disease

    A combination of social, mental, and physical stimulation is the best medicine for a healthy life. Even after a diagnosis of Alzheimer’s disease, stimulating activities should be continued and modified as needed. Regular exercise and a nutritious diet are also important for Alzheimer’s patients. Here are a few ways to maintain a healthy lifestyle, which can help patients cope better with the impact of this disorder.

    Friday, June 3, 2016
  • Fact Sheet

    Glaucoma Treatments

    The most common treatments for glaucoma are eye drops and, rarely, pills. If you are using these medications. be aware of their purpose and potential side effects, which should be explained by a medical professional.

    Monday, July 10, 2017
  • Fact Sheet

    Clinical Trial Information for Glaucoma

    It can take many years for a potential treatment for glaucoma to work its way from the laboratory, through rigorous testing and, finally, to become approved by the U.S. Food and Drug Administration (FDA). Learn more about the process and how clinical trials work.

    Tuesday, October 17, 2017

    • Don't miss out.
    Receive research updates, inspiring stories, and expert advice
    Keep me imformed about: *
    Please select at least one.
    You must select at least one disease category.
    Please enter your first name.
    Please enter your last name.

    Join us in the fight to end brain and eye disease

    • 1 in 16 Americans over age 40 has either Alzheimer's, macular degeneration, or glaucoma.

    • Asset 1

      BrightFocus has funded more than $170 million in groundbreaking research to eradicate brain and eye disease. 

    • Global Impact

      BrightFocus makes innovative science possible around the world—1,380 research projects involving more than 4,140 scientists in 22 countries. 

    • You can make a difference. 
      Support BrightFocus-funded research to end brain and eye diseases in our lifetime.

      Give Now